Bank Of New York Mellon Corp Opti Nose, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.68 - $3.7 $93,854 - $206,704	55,866 New	55,866 $103,000
Q3 2022 Nov 14, 2022	SELL	$3.43 - $4.01 $19,029 - $22,247	-5,548 Reduced 8.31%	61,238 $224,000
Q2 2022 Aug 15, 2022	BUY	$1.76 - $3.82 $18,105 - $39,296	10,287 Added 18.21%	66,786 $244,000
Q1 2022 May 11, 2022	SELL	$1.77 - $2.93 $3,136 - $5,191	-1,772 Reduced 3.04%	56,499 $140,000
Q4 2021 Feb 11, 2022	SELL	$1.55 - $3.1 $6,533 - $13,066	-4,215 Reduced 6.75%	58,271 $95,000
Q3 2021 Nov 12, 2021	SELL	$2.35 - $3.16 $397 - $534	-169 Reduced 0.27%	62,486 $187,000
Q2 2021 Aug 11, 2021	SELL	$2.91 - $3.83 $216,108 - $284,431	-74,264 Reduced 54.24%	62,655 $194,000
Q1 2021 May 13, 2021	SELL	$3.47 - $4.75 $4,524 - $6,194	-1,304 Reduced 0.94%	136,919 $505,000
Q4 2020 Feb 09, 2021	SELL	$3.2 - $4.98 $19,705 - $30,666	-6,158 Reduced 4.27%	138,223 $572,000
Q3 2020 Nov 12, 2020	BUY	$3.69 - $7.09 $3,420 - $6,572	927 Added 0.65%	144,381 $563,000
Q2 2020 Aug 12, 2020	SELL	$3.58 - $7.44 $59,012 - $122,640	-16,484 Reduced 10.31%	143,454 $1.07 Million
Q1 2020 May 06, 2020	BUY	$3.49 - $9.2 $9,559 - $25,198	2,739 Added 1.74%	159,938 $718,000
Q4 2019 Feb 14, 2020	BUY	$6.27 - $11.41 $31,130 - $56,650	4,965 Added 3.26%	157,199 $1.45 Million
Q3 2019 Nov 07, 2019	SELL	$4.75 - $8.38 $17,285 - $30,494	-3,639 Reduced 2.33%	152,234 $1.07 Million
Q2 2019 Aug 12, 2019	BUY	$6.4 - $10.94 $60,902 - $104,105	9,516 Added 6.5%	155,873 $1.1 Million
Q1 2019 May 14, 2019	SELL	$6.1 - $10.3 $18,031 - $30,446	-2,956 Reduced 1.98%	146,357 $1.51 Million
Q4 2018 Feb 11, 2019	SELL	$5.84 - $11.92 $359,142 - $733,044	-61,497 Reduced 29.17%	149,313 $926,000
Q3 2018 Nov 09, 2018	BUY	$12.43 - $29.76 $404,236 - $967,824	32,521 Added 18.24%	210,810 $0
Q2 2018 Aug 06, 2018	BUY	$18.75 - $28.46 $3.05 Million - $4.63 Million	162,851 Added 1054.87%	178,289 $4.99 Million
Q1 2018 May 15, 2018	BUY	$15.91 - $20.82 $245,618 - $321,419	15,438 New	15,438 $309,000

Others Institutions Holding OPTN

# of Institutions

Shares Held

88.3M

Call Options Held

Put Options Held

Mvm Partners, LLC Boston, MA

14.6M
Shares

$5.55 Million
10.4% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

14.4M
Shares

$5.46 Million
0.57% of portfolio
Great Point Partners LLC Greenwich, CT

12.9M
Shares

$4.89 Million
3.98% of portfolio
Stonepine Capital Management, LLC Bend, OR

5.69M
Shares

$2.16 Million
2.41% of portfolio
Kingdon Capital Management, L.L.C. New York, NY

5.6M
Shares

$2.13 Million
0.45% of portfolio

View Full List

About OptiNose, Inc.

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $31.6M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

More about OPTN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account